“Upsher Smith Recalls Propranolol Capsules Due to Dissolution Failure.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48481-upsher-smith-laboratories-inc-recalls-propranolol-hydrochloride-extended-release-capsules. Based on FDA recall #D-160-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-160-2013%22&limit=1).
Upsher Smith Laboratories, Inc. voluntarily recalled Propranolol Hydrochloride Extended-release Capsules due to failed dissolution test requirements, the FDA said on Nov. 20, 2012. The recall affects 60 bottles distributed in Florida and New Jersey.
UPC: 3 0245-0085-11 9 (also listed as 00302450085119)
Lot #: 308198
Expiration Date: 03/2014
Quantity: 60 bottles
The hazard
The recalled Propranolol Hydrochloride Extended-release Capsules failed dissolution test requirements. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Upsher Smith Laboratories, Inc. has had four other recalls since Dec. 10, 2012. Other recent recalls of similar products include Golden State Medical's Prasugrel HCl 10mg Tablets recall (Aug. 21, 2026), Teva's Metoprolol Succinate Tablets recall for failed dissolution specifications (Jan. 29, 2026), and Supernus' Trokendi XR 50mg Capsules recall for failed dissolution specifications (Aug. 31, 2026).
How to tell if you have this one
Check your bottle for NDC 0245-0085-11, UPC 3 0245-0085-11 9, Lot #308198, and an expiration date of 03/2014. The product is manufactured by Upsher Smith Laboratories, Inc. in Minneapolis, MN.
Brand
Upsher Smith
Product
Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Verify if your Propranolol bottle matches the recalled lot number and expiration date listed above.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider to determine how to proceed with your treatment plan.
Where it went and when
Where it was distributed
Distributed in Florida and New Jersey.
Listed by the agency
Not listed
FDA distribution: “FL, NJ.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, New Jersey.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-160-2013 (November 20, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-160-2013 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.